CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Cash flows from operating activities
Net loss	$ (2,560,119)	$ (491,837)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation expense	4,251	4,251
Gain on debt extinguishment	0	(2,434,661)
Decrease in fair value of derivative liabilities	0	2,795
Amortization of discount on notes payable	945,552	759,869
Accrued interest on patents purchased	0	52,067
Amortization of patents and acquired contracts	405,995	405,995
Stock-based compensation	91,234	130,358
Changes in operating assets and liabilities
Accounts receivable	9,797	(6,281)
Prepaid expenses and other current assets, net	(216,249)	133,931
Deferred expenses	7,937	20,875
Accounts payable	58,594	(95,287)
Accrued expenses and other current liabilities	36,188	172,238
Deferred revenue	(100,000)	150,000
Net cash used in operating activities	(1,316,820)	(1,195,687)
Cash flows from financing activities
Proceeds from issuance of preferred stock, net of issuance costs	0	2,175,000
Payments on senior notes payable	0	(658,757)
Payments on related party note payable	0	(25,000)
Net cash provided by financing activities	0	1,491,243
Net increase (decrease) in cash and cash equivalents	(1,316,820)	295,556
Cash and cash equivalents, beginning of period	1,476,774	554,556
Cash and cash equivalents, end of period	159,954	850,112
Supplemental disclosures of cash flow information
Cash paid for interest	0	218,139
Supplemental disclosures of non-cash investing and financing activities
Fair value of common stock warrants	$ 341,535	$ 760,461